Table 2 Univariate analysis of disease-free and overall survival for 42 patients with type B2 thymoma
Variable | Five-year disease-free survival rate (%) | P | 5-year overall survival rate (%) | P |
|---|---|---|---|---|
Gender | 0.117 | 0.061 | ||
Male | 44.9 | 87.5 | ||
Female | 75.1 | 82.8 | ||
Age | 0.479 | 0.971 | ||
<50 | 62.1 | 87.7 | ||
≥50 | 62.9 | 81.4 | ||
Stage | 0.000 | 0.000 | ||
I + II | 79.2 | 95.2 | ||
III + IV | 33.4 | 55.2 | ||
Resection | 0.009 | 0.000 | ||
Yes | 67.8 | 93.7 | ||
No | 42.9 | 51.4 | ||
Adjuvant treatment | 0.204 | 0.023 | ||
Yes | 66.5 | 95.7 | ||
No | 58.9 | 71.5 | ||
Tumor size | 0.772 | 0.372 | ||
>7 cm | 56.2 | 90.7 | ||
≤7 cm | 80.8 | 82.4 | ||
Myasthenia gravis | 0.895 | 0.702 | ||
Yes | 51.4 | 83.3 | ||
No | 64.7 | 84.9 |